Shuttle Pharmaceuticals Holdings, Inc.SHPHNASDAQ
Loading
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | -34.42% | -74.63% | -75.40% | -89.09% | -78.37% |
| Weighted Average Shares Diluted Growth | -34.42% | -74.63% | -75.40% | -89.09% | -78.37% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | -100.00% | -100.00% | -100.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -90.87% | -57.89% | +11.70% | +95.68% | +425.99% |
| Book Value per Share Growth | +0.00% | -31.08% | +383.64% | +4024.88% | +0.00% |
| Debt Growth | -41.63% | +7.89% | -14.04% | -38.29% | +18.27% |
| R&D Expense Growth | +34.00% | +128.02% | +168.54% | +58.82% | -32.64% |
| SG&A Expenses Growth | +198.03% | -6.99% | +72.44% | +244.70% | -19.90% |